UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cardiac xenotransplantation: recent preclinical progress with 3-month median survival.

McGregor, CGA; Davies, WR; Oi, K; Teotia, SS; Schirmer, JM; Risdahl, JM; Tazelaar, HD; ... Logan, JS; + view all (2005) Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg , 130 (3) pp. 844-851. 10.1016/j.jtcvs.2005.04.017.

Full text not available from this repository.

Abstract

OBJECTIVES: Transplantation is limited by a lack of human organ donors. Organs derived from animals, most likely the pig, represent a potential solution to this problem. For the heart, 90-day median graft survival of life-supporting pig hearts transplanted to nonhuman primates has been considered a reasonable standard for entry into the clinical arena. Overcoming the immune barrier to successful cardiac xenotransplantation is most appropriately first explored with the non-life-supporting heterotopic model. METHODS: We performed a series of 7 heterotopic heart transplantations from CD46 transgenic pigs to baboons using a combination of therapeutic agents largely targeted at controlling the synthesis of anti-pig antibodies. Rituximab (anti-CD20) and Thymoglobulin (rabbit antithymocyte globulin [ATG]; SangStat Medical Corp, Fremont, Calif) were used as induction therapy. Baseline immunosuppression consisted of splenectomy, tacrolimus, sirolimus, steroids, and TPC (an anti-Gal antibody therapeutic). Rejection events were not treated. RESULTS: By using Kaplan-Meier analysis, median graft survival was 96 days (range, 15-137 days; 95% confidence interval, 38-99 days). Only 2 grafts were lost as a result of rejection, as defined by cessation of graft palpation. There was no evidence of a consumptive coagulopathy, infectious complications were treatable, and no posttransplantation lymphoproliferative disorders occurred. No cellular infiltration was observed. CONCLUSIONS: This study reports the longest median survival to date (96 days) of pig hearts transplanted heterotopically into baboons. Duplication of these results in the orthotopic life-supporting position could bring cardiac xenotransplantation to the threshold of clinical application.

Type: Article
Title: Cardiac xenotransplantation: recent preclinical progress with 3-month median survival.
Location: United States
DOI: 10.1016/j.jtcvs.2005.04.017
Keywords: Animals, Animals, Genetically Modified, Antibodies, Antigens, CD, Disaccharides, Graft Rejection, Graft Survival, Heart Transplantation, Immunoglobulin G, Immunoglobulin M, Immunohistochemistry, Immunosuppressive Agents, Membrane Cofactor Protein, Membrane Glycoproteins, Myocardial Contraction, Myocardium, Papio, Survival Rate, Swine, Transplantation, Heterologous, Transplantation, Heterotopic
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science
URI: http://discovery.ucl.ac.uk/id/eprint/90860
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item